Anthony Boral
Overview
Anthony Boral received an average of $2M in total compensation, including $398K in salary, at Blueprint Medicines from 2015 to 2019.
Source: SEC filings on April 29, 2020, April 29, 2019, April 27, 2018, and April 28, 2016.
Related executives
We found ten more executives who work or worked at Blueprint Medicines.
Fouad Namouni
Blueprint Medicines
President, Research and Development
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
Michael Landsittel
Blueprint Medicines
Chief Financial Officer
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
Christopher Murray
Blueprint Medicines
Senior Vice President, Technical Operations
Kate Haviland
Blueprint Medicines